The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.10 - Manufacture of basic pharmaceutical products
500 jobs Number of planned job losses
Announcement Date
1 July 2025
Employment effect (start)
1 July 2025
Foreseen end date
31 December 2026
Description
CSL, an Australian biopharmaceutical company, announced approximately 500 job cuts affecting its research and development (R&D) unit at its Marburg site in Hesse, Germany.
The job losses are linked to the company’s decision to gradually close its R&D activities at the site as part of a global strategic realignment, with the closure expected to be completed by the end of 2026. The positions affected are mainly permanent full-time white-collar jobs in research and development.
The exact measures for implementing the redundancies are still under discussion, with the company currently negotiating with the works council to find solutions for the affected employees. No details have been provided regarding indirect job losses, although impacts on related activities cannot be excluded. Employee representatives are involved in ongoing negotiations, while local authorities have strongly criticised the decision. The mayor of Marburg described the planned closure as a “serious blow” to the city and the wider region and indicated that support measures would be explored.
CSL operates a major site in Marburg employing around 3,000 people, making it the largest site within the group. Despite the planned closure of R&D, the company has announced plans to invest approximately €400 million in expanding its production activities at the site.
Eurofound (2025), CSL Innovation, Closure in Germany, factsheet number 204460, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/204460.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...